Pharmaceutical Process Engineering
暫譯: 藥品製程工程

Hickey, Anthony J.

Pharmaceutical Process Engineering
  • 出版商: CRC
  • 出版日期: 2026-07-07
  • 售價: $8,480
  • 貴賓價: 9.5 折 $8,056
  • 語言: 英文
  • 頁數: 234
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 1032730110
  • ISBN-13: 9781032730110
  • 相關分類: 材料科學 Meterials

    • 尚未上市，無法訂購

相關主題

商品描述

With step-by-step methods of drug production and knowledge of major unit operations and key concepts of pharmaceutical engineering, this guide will help to improve communication among the varied professionals working in the pharmaceutical industry. The updated volume reflects the acceleration occurring in processes to support new product development as the revolution initiated by characterization of the human genome at the turn of the millennium has an impact in transforming the treatment of disease.

Key Features

  • The thoroughly revised and expanded professional text illustrates how materials that are being processed have evolved as the understanding of the cell biology and biochemistry of disease has improved and new treatments have emerged based on the products of biotechnology.
  • Emphasizes the importance of pharmaceutical engineering and addresses the advances in disease therapy including their implications for pharmaceutical process engineering.
  • Each topic has been updated to reflect new developments occurring in the last decade.
  • Describes biosynthesis, of particular relevance to proteins and nucleic acids as well as gene transfer by transfection and editing used currently in cell therapies for a variety of rare diseases.
  • Exciting new chapter on artificial intelligence and machine learning as tools for process optimization.

商品描述(中文翻譯)

本指南提供逐步的藥物生產方法以及製藥工程的主要單元操作和關鍵概念，旨在改善製藥行業中各類專業人士之間的溝通。更新的版本反映了支持新產品開發過程中發生的加速變化，因為在千禧年之交，人類基因組的特徵化所引發的革命正在改變疾病治療的方式。

主要特色

  • 這本經過徹底修訂和擴充的專業文本說明了隨著對細胞生物學和疾病生物化學理解的提高，正在加工的材料如何演變，以及基於生物技術產品的新療法的出現。
  • 強調製藥工程的重要性，並探討疾病治療的進展及其對製藥過程工程的影響。
  • 每個主題都已更新，以反映過去十年中發生的新發展。
  • 描述了生物合成，特別是與蛋白質和核酸相關的生物合成，以及目前在各種罕見疾病的細胞療法中使用的轉染和編輯基因轉移技術。
  • 新增令人興奮的章節，探討人工智慧和機器學習作為過程優化的工具。

作者簡介

Anthony J. Hickey is Distinguished Fellow Emeritus at RTI International, Research Triangle Park, NC; Professor Emeritus of Pharmacoengineering and Molecular Pharmaceutics of the Eshelman School of Pharmacy; and Adjunct Professor of Biomedical Engineering in the School of Medicine at the University of North Carolina at Chapel Hill. He is a Fellow of the American Association for the Advancement of Science, the American Association of Pharmaceutical Scientists, the Academy of Pharmaceutical Sciences of Great Britain, the Royal Society of Biology, the Royal Society of Medicine, and the National Academy of Inventors. He received the Research Achievement Award of the Particulate Presentations and Design Division of the Powder Technology Society of Japan, the David W Grant Award in Physical Pharmacy of the American Association of Pharmaceutical Scientists, Thomas T Mercer Joint Prize for Excellence in Inhaled Medicines and Pharmaceutical Aerosols of the American Association for Aerosol Research and the International Society for Aerosols in Medicine, and the Ralph Shangraw Memorial Award for Excipient and Excipient Technology of the International Pharmaceutical Excipient Consortium Foundation. He is founder (and formerly President and CEO) of Cirrus Pharmaceuticals, Inc.; founder (formerly CSO) of Oriel Therapeutics, Inc; CEO of Astartein, LLC.; Member of the Board of First Flight Venture Center, Inspiring Pty Ltd., and KAER Biotherapeutics; Chair of the USP Joint Sub-Committee on Nanotechnology; and Member of the USP Pharmaceutical Dosage Forms Expert Committee (DFEC) and Inhalation Sub-Committee of the DFEC of the United States Pharmacopeia. He consults on multidisciplinary research programs in the field of pulmonary drug and vaccine delivery for the treatment and prevention of a variety of diseases and serves on numerous editorial and scientific advisory boards.

作者簡介(中文翻譯)

安東尼·J·希基是美國RTI國際公司的榮譽特聘研究員，位於北卡羅來納州的研究三角園；是埃舍爾曼藥學院的藥物工程與分子藥劑學榮譽教授；以及北卡羅來納大學教堂山分校醫學院生物醫學工程的兼任教授。他是美國科學促進會、美國藥學科學家協會、英國藥學科學學院、皇家生物學會、皇家醫學學會以及全國發明家學院的院士。他獲得了日本粉體技術學會顆粒展示與設計部門的研究成就獎、美國藥學科學家協會的物理藥學大衛·W·格蘭特獎、美國氣溶膠研究協會及國際醫學氣溶膠學會的吸入藥物與藥用氣溶膠卓越托馬斯·T·梅瑟聯合獎，以及國際藥用輔料聯盟基金會的拉爾夫·香格勞紀念獎。他是Cirrus Pharmaceuticals, Inc.的創始人（曾任總裁兼首席執行官）；Oriel Therapeutics, Inc.的創始人（曾任首席科學官）；Astartein, LLC.的首席執行官；First Flight Venture Center、Inspiring Pty Ltd.和KAER Biotherapeutics的董事會成員；美國藥典（USP）納米技術聯合小組委員會的主席；以及美國藥典藥物劑型專家委員會（DFEC）和DFEC的吸入小組委員會的成員。他在肺部藥物和疫苗傳遞的多學科研究計劃中提供諮詢，旨在治療和預防各種疾病，並擔任多個編輯和科學諮詢委員會的成員。

類似商品

最後瀏覽商品 (1)